Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2

Hepatology

Volumn 32, Issue 1, 2000, Pages 82-86

  Fattinger, Karin ^a   Cattori, Valentino ^a   Hagenbuch, Bruno ^a   Meier, Peter J ^a   Stieger, Bruno ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; ESTRADIOL 17 GLUCURONIDE; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; RIFAMPICIN; RIFAMYCIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOPUS LAEVIS;

EID: 0034235341     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8539     Document Type: Article

References (33)

1. 1. Bergamini N, Fowst G. Rifamycin SV. A review. Arzneimittelforschung 1965;15(Suppl):951-1002.
2. 2. Acocella G. Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis 1983;5:S428-S432.
3. 3. Acocella G. Le rifamicine. Giornale italiano di chemioterapia 1983;30: 1-24.
4. 4. Acocella G, Nicolis FB, Tenconi LT. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man. Gastroenterology 1965;49:521-525.
5. 5. Kenwright S, Levi AJ. Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications. Lancet 1973;2:1401-1405.
6. 6. Berg JD, Pandov HI, Sammons HG. Serum total bile acid levels in patients receiving rifampicin and isoniazid. Ann Clin Biochem 1984;21: 218-222.
7. 7. Galeazzi R, Lorenzini I, Orlandi F. Rifampicin-induced elevation of serum bile acids in man. Dig Dis Sci 1980;25:108-112.
8. 8. Anwer MS, Kroker R, Hegner D. Inhibition of hepatic uptake of bile acids by rifamycins. Naunyn Schmiedebergs Arch Pharmacol 1978;302: 19-24.
9. 9. Kiss IJ, Farago E, Kiss B, Varhelyi I. Pharmacokinetic study of rifampicin in biliary surgery. Int J Clin Pharmacol Biopharm 1978;16:105-109.
10. 10. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specifity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. HEPATOLOGY 1997;26:1667-1677.
11. 11. Noe B, Hagenbuch B, Stieger B, Meier PJ. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci U S A 1997;94:10346-10350.
12. 12. Reichel C, Gao B, Van Montfoort J, Cattori V, Rahner C, Hagenbuch B, Stieger B, et al. Localization and function of the organic anion transporting polypeptide Oatp2 in rat liver. Gastroenterology 1999;117:688-695.
13. 13. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 1999;290:153-157.
14. 14. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969;43:506-520.
15. 15. Boelsterli UA, Bouis P, Brouillard JF, Donatsch P. In vitro toxicity assessment of cyclosporin A and its analogs in a primary rat hepatocyte culture model. Toxicol Appl Pharmacol 1988;96:212-221.
16. 16. Liang D, Hagenbuch B, Stieger B, Meier PJ. Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. HEPATOLOGY 1993;18:1162-1166.
17. 17. Boelsterli UA, Zimmerli B, Meier PJ. Identification and characterization of a basolateral dicarboxylate/cholate antiport system in rat hepatocytes. Am J Physiol 1995;268:G797-G805.
18. 18. Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci U S A 1991;88:10629-10633.
19. 19. Kullak-Ublick GA, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Functional characterization of the basolateral rat liver organic anion transporting polypeptide. HEPATOLOGY 1994;20:411-416.
20. 20. Hagenbuch B, Lubbert H, Stieger B, Meier PJ. Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes. J Biol Chem 1990;265:5357-5360.
21. 21. Acocella G, Billing BH. The effect of rifamycin SV on pigment excretion in rats. Gastroenterology 1965;49:526-530.
22. 22. Kroker R, Anwer MS, Hegner D. The interaction of rifamycin SV with hepatic transport of taurocholic acid in the isolated perfused rat liver. Naunyn-Schmiedebergs Arch Pharmacol 1978;302:323-327.
23. 23. Laperche Y, Graillot C, Arondel J, Berthelot P. Uptake of rifampicin by isolated rat liver cells. Interaction with sulfobromophthalein uptake and evidence for separate carriers. Biochem Pharmacol 1979;28:2065-2069.
24. 24. Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975;105(Suppl):1-30.
25. 25. Hagenbuch B, Scharschmidt BF, Meier PJ. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem J 1996;316:901-904.
26. 26. Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 1994;93:1326-1331.
27. 27. Petzinger E. Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport. Rev Physiol Biochem Pharmacol 1994;123:47-211.
28. 28. Ahlberg J, Angelin B, Bjorkhem I, Einarsson K. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology 1977;73:1377-1382.
29. 29. van Montfoort JE, Hagenbuch B, Fattinger K, Müller M, Groothuis GMM, Meijer DKF, Meier PJ. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. J Pharmacol Exp Ther 1999;291:147-152.
30. 3-exchange. J Biol Chem 1997;272:26340-26345.
31. 31. Li L, Lee TK, Meier PJ, Ballatori N. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem 1998;273:16184-16191.
32. 32. Eckhardt U, Horz JA, Petzinger E, Stuber W, Reers M, Dickneite G, Daniel H, et al. The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide. HEPATOLOGY 1996;24:380-384.
33. 33. Kakyo M, Unno M, Tokui T, Nakagomi R, Nishio T, Iwasashi H, Nakai D, et al. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter r1st-1. Gastroenterology 1999;117: 770-775.